Continues with Total Product Revenue of $73.7M in 4Q24 and $164.1M in FY24, Achieving Upper End of FY24 Guidance Range of $160M-$165M Reaffirming FY25 Total Product Revenue Guidance of $450M-$475M ...

"The best part of the job is hopefully curing somebody of cancer and giving them back the life they and their family wouldn’t ...

The following were consistently prognostic across meta-analyses: febrile convulsions, hippocampal sclerosis, focal abnormal MRI, Single-Photon Emission Computed Tomography (SPECT) coregistered to MRI, ...

Revoras bridges the gap between radiology and surgery by transforming imaging data into interactive, AI-enhanced 3D models that surgeons can rely on for precision-driven pre-op planning ...